Trusted long-term partner for primary packaging products and drug-delivery devices

As the global prevalence of obesity and diabetes continues to rise, the demand for safe, reliable, and scalable therapeutic solutions is growing rapidly. Supporting this evolution requires more than supply capacity—it demands deep expertise, quality by design, and long-term partnership.

We provide high-performance primary packaging solutions together with customized drug-delivery devices, including advanced pen injectors, specifically designed to meet the requirements of GLP-1–based therapies and insulin products.